CSL (OTCMKTS:CSLLY) Shares Gap Down – What’s Next?

CSL Limited Sponsored ADR (OTCMKTS:CSLLY)’s stock price gapped down before the market opened on Wednesday . The stock had previously closed at $59.72, but opened at $57.45. CSL shares last traded at $57.43, with a volume of 1,320 shares changing hands.

Analyst Ratings Changes

CSLLY has been the topic of a number of recent analyst reports. Zacks Research lowered shares of CSL from a “hold” rating to a “strong sell” rating in a research report on Tuesday, November 18th. Canaccord Genuity Group upgraded CSL from a “hold” rating to a “strong-buy” rating in a report on Tuesday, October 28th. Two research analysts have rated the stock with a Strong Buy rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock has an average rating of “Buy”.

CSL Trading Down 2.4%

The company has a quick ratio of 1.12, a current ratio of 2.46 and a debt-to-equity ratio of 0.50. The firm has a 50 day moving average of $62.09 and a 200-day moving average of $71.57.

About CSL

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.